glutamic acid has been researched along with Hyperactivity, Motor in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.00) | 18.2507 |
| 2000's | 20 (66.67) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, AY; Chuang, HH; Huang, CS; Lai, YC; Wang, GH; Yang, YC; Yeh, JY | 1 |
| Dalhoff, Z; Eggerichs, MR; Elshikh, AH; Fettig, SL; Karki, P; Nelson, BE; Ramakrishnan, L; Shrestha, B | 1 |
| Andrén, A; Arvidsson, E; Dumas, S; Leão, RN; Lévesque, D; Mahmoudi, S; Nordenankar, K; Pupe, S; Rajagopalan, A; Schweizer, N; Smith-Anttila, CJ; Wallén-Mackenzie, Å | 1 |
| Pupe, S; Schweizer, N; Wallén-Mackenzie, Å | 1 |
| Konsolaki, E; Skaliora, I | 1 |
| Fontenelle, LF; Mendlowicz, MV | 1 |
| Becker, A; Berek, I; Grecksch, G; Härtl, A; Höllt, V; Schröder, H | 1 |
| He, S; Jia, H; Li, N; Meng, Q; Sun, L; Wu, S; Zhao, X | 1 |
| Antkiewicz-Michaluk, L; Gołembiowska, K; Michaluk, J; Pietraszek, M; Romańska, I; Wasik, A | 1 |
| Calamandrei, G; Ferrante, A; Martire, A; Pieri, M; Popoli, P; Rungi, A; Venerosi, A; Zona, C | 1 |
| Han, W; Qi, J; Song, M; Wang, F; Wu, C; Yang, J; Zhang, L; Zhao, S | 1 |
| Ballard, TM; Bluethmann, H; Borroni, E; Higgins, GA; Kemp, JA; Kew, JN; Mutel, V; Ouagazzal, AM; Pauly-Evers, M | 1 |
| Anderson, JJ; Baccei, CS; Bristow, LJ; Campbell, UC; Correa, LD; Lorrain, DS; Pinkerton, AB; Rodriguez, DE; Rowe, B; Schaffhauser, H; Varney, MA; Vernier, JM | 1 |
| Korada, S; Raballo, R; Shashikant, CS; Shin, DM; Simeone, A; Taylor, JR; Vaccarino, F | 1 |
| Carlsson, A; Carlsson, ML; Gullme, M; Markinhuhta, KR; Nilsson, M; Pettersson, F; Sonesson, C | 1 |
| Baccei, CS; Bristow, LJ; Campbell, UC; Daggett, LP; Lorrain, DS; Pinkerton, AB; Rodriguez, DE; Rowe, BA; Schaffhauser, H; Vernier, JM | 1 |
| Lu, YJ; Zhang, HY; Zhang, SM; Zheng, XX; Zhou, J | 1 |
| Bast, T; Feldon, J; Ferger, B; Murphy, CA; Peleg-Raibstein, D; Pezze, MA; Zhang, WN | 1 |
| de Lago, E; Di Marzo, V; Fernández-Ruiz, J; Ramos, JA; Urbani, P | 1 |
| Benítez-Díaz, P; Dávila-Ovalles, R; Miranda-Contreras, L; Palacios-Prü, E; Peña-Contreras, Z | 1 |
| Bubenikova-Valesova, V; Klement, D; Stuchlik, A; Vales, K | 1 |
| Bedogni, F; Collu, M; Fadda, P; Fresu, A; Racagni, G; Riva, MA | 1 |
| Anthony, DC; Blamire, AM; Broom, KA; Griffin, JL; Lowe, JP; Perry, VH; Scott, H; Sibson, NR; Styles, P | 1 |
| Henkemeyer, M; Kromer, LF; Richards, AB; Scheel, TA; Wang, K | 1 |
| Celikel, T; Daws, LC; Feyder, M; Hefner, K; Holmes, A; Horton, RE; Karlsson, RM; Owens, WA; Sprengel, R; Wiedholz, LM | 1 |
| Abraini, JH; David, HN; Rouillon, C | 1 |
| Bloom, FE; Kreifeldt, M; Mehta, PP; Parsons, LH; Raber, J; Weiss, F; Wilson, MC | 1 |
| Carlsson, A; Carlsson, ML; Martin, P; Nilsson, M; Sorensen, SM; Waters, N; Waters, S | 1 |
| Conquet, F; Mao, L; Wang, JQ | 1 |
| Desiraju, T; Shailesh Kumar, MV | 1 |
30 other study(ies) available for glutamic acid and Hyperactivity, Motor
| Article | Year |
|---|---|
Conveyance of cortical pacing for parkinsonian tremor-like hyperkinetic behavior by subthalamic dysrhythmia.
Topics: 4-Aminopyridine; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Glutamic Acid; Humans; Hyperkinesis; Male; Membrane Potentials; Mice, Inbred C57BL; Motor Cortex; Muscle, Skeletal; Optogenetics; Parkinson Disease, Secondary; Rats; Rats, Wistar; Subthalamic Nucleus; Synapses; Synaptic Transmission; Tremor | 2021 |
Riluzole attenuates the effects of chemoconvulsants acting on glutamatergic and GABAergic neurotransmission in the planarian Dugesia tigrina.
Topics: Animals; Behavior, Animal; Convulsants; Dizocilpine Maleate; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Hyperkinesis; N-Methylaspartate; Planarians; Receptors, Glutamate; Riluzole; Semicarbazides; Synaptic Transmission | 2013 |
Limiting glutamate transmission in a Vglut2-expressing subpopulation of the subthalamic nucleus is sufficient to cause hyperlocomotion.
Topics: Animals; Dopamine; Excitatory Postsynaptic Potentials; Glutamic Acid; Homeobox Protein PITX2; Homeodomain Proteins; Hyperkinesis; Immunohistochemistry; In Situ Hybridization; Maze Learning; Mice; Mice, Knockout; Reverse Transcriptase Polymerase Chain Reaction; Subthalamic Nucleus; Synaptic Transmission; Transcription Factors; Vesicular Glutamate Transport Protein 2 | 2014 |
Reply to Konsolaki and Skaliora: Habituation, hyperlocomotion, and "genuine hyperlocomotion".
Topics: Animals; Glutamic Acid; Hyperkinesis; Subthalamic Nucleus; Synaptic Transmission; Vesicular Glutamate Transport Protein 2 | 2015 |
Motor vs. cognitive elements of apparent "hyperlocomotion": a conceptual and experimental clarification.
Topics: Animals; Glutamic Acid; Hyperkinesis; Subthalamic Nucleus; Synaptic Transmission; Vesicular Glutamate Transport Protein 2 | 2015 |
The Wernicke-Kleist-Leonhard "short-circuiting": a missing link between attention deficit hyperactivity disorder, Tourette syndrome, and obsessive-compulsive disorder?
Topics: Attention Deficit Disorder with Hyperactivity; Glutamic Acid; Humans; Hyperkinesis; Models, Neurological; Obsessive-Compulsive Disorder; Psychotic Disorders; Tourette Syndrome | 2008 |
Ampullosporin A, a peptaibol from Sepedonium ampullosporum HKI-0053 with neuroleptic-like activity.
Topics: Animals; Antipsychotic Agents; Anxiety; Apomorphine; Avoidance Learning; Body Temperature; Brain; Catalepsy; Dizocilpine Maleate; Dopamine; Glutamic Acid; Hyperkinesis; Male; Motor Activity; Peptaibols; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Rotarod Performance Test; Social Behavior | 2009 |
Isolation rearing induces social and emotional function abnormalities and alters glutamate and neurodevelopment-related gene expression in rats.
Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Disks Large Homolog 4 Protein; Exploratory Behavior; Gene Expression Regulation, Developmental; Glutamic Acid; Hippocampus; Hyperkinesis; Intracellular Signaling Peptides and Proteins; Male; Maze Learning; Membrane Proteins; Mood Disorders; Neuropeptides; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Social Isolation | 2009 |
1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Brain; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hyperkinesis; Inhibition, Psychological; Male; Maze Learning; Memory Disorders; Microdialysis; Motor Activity; Neurochemistry; Prefrontal Cortex; Rats; Rats, Wistar; Reflex, Startle; Tetrahydroisoquinolines | 2009 |
Complex behavioral and synaptic effects of dietary branched chain amino acids in a mouse model of amyotrophic lateral sclerosis.
Topics: Amino Acids, Branched-Chain; Amyotrophic Lateral Sclerosis; Animals; Behavior, Animal; Brain; Diet; Dietary Supplements; Glucose Transporter Type 1; Glutamic Acid; Hyperkinesis; In Vitro Techniques; Male; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neurons; Organ Specificity; Pain Threshold; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Severity of Illness Index; Synaptic Transmission; Time Factors | 2011 |
NMDA receptors in the medial prefrontal cortex and the dorsal hippocampus regulate methamphetamine-induced hyperactivity and extracellular amino acid release in mice.
Topics: Amino Acids; Animals; Blotting, Western; Central Nervous System Stimulants; Excitatory Amino Acid Agonists; Extracellular Space; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Hyperkinesis; Kainic Acid; Male; Methamphetamine; Mice; Microdialysis; N-Methylaspartate; Neural Pathways; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Vesicular Glutamate Transport Protein 2 | 2012 |
Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Binding Sites; Binding, Competitive; Biogenic Amines; Corpus Striatum; Dose-Response Relationship, Drug; Drug Resistance; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Agonists; Gene Targeting; Glutamic Acid; Glycine; Heterozygote; Hippocampus; Hyperkinesis; In Vitro Techniques; Long-Term Potentiation; Mice; Mice, Neurologic Mutants; Neurons; Patch-Clamp Techniques; Phenotype; Point Mutation; Receptors, N-Methyl-D-Aspartate; Serine; Stereoisomerism; Stereotyped Behavior | 2002 |
Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Analysis of Variance; Animals; Area Under Curve; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; Humans; Hyperkinesis; In Vitro Techniques; Ketamine; Male; Microdialysis; Motor Activity; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Metabotropic Glutamate; Schizophrenia; Serotonin; Sulfur Isotopes; Time Factors; Trifluoroethanol; Xanthenes | 2003 |
Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice.
Topics: Adrenergic alpha-Agonists; Amphetamine; Animals; Cell Differentiation; Cell Division; Frontal Lobe; Glutamic Acid; Guanfacine; Humans; Hyperkinesis; Mice; Mice, Transgenic; Nervous System Malformations; Neural Inhibition; Pyramidal Cells; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Adrenergic, alpha-2; Receptors, Fibroblast Growth Factor; Signal Transduction; Stereotypic Movement Disorder; Temporal Lobe | 2004 |
The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition.
Topics: Animals; Autistic Disorder; Behavior, Animal; Cognition; Dizocilpine Maleate; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Grooming; Haloperidol; Hyperkinesis; Male; Mice; Motor Activity; Piperidines; Schizophrenia | 2004 |
Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor.
Topics: Acetophenones; Allosteric Regulation; Animals; Behavior; Brain; Dose-Response Relationship, Drug; Glutamic Acid; Hyperkinesis; Norepinephrine; Rats; Receptors, Metabotropic Glutamate; Schizophrenia; Structure-Activity Relationship | 2004 |
Inhibitory effects of jujuboside A on EEG and hippocampal glutamate in hyperactive rat.
Topics: Animals; Behavior, Animal; Diazepam; Electroencephalography; Glutamic Acid; Hippocampus; Hyperkinesis; Male; Penicillins; Rats; Rats, Sprague-Dawley; Saponins | 2005 |
Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats.
Topics: Animals; Dopamine; Excitatory Amino Acid Agonists; Extracellular Fluid; Glutamic Acid; Hippocampus; Hyperkinesis; Male; Microdialysis; N-Methylaspartate; Neural Pathways; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Ventral Tegmental Area | 2005 |
Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease.
Topics: Animals; Brain Chemistry; Capsaicin; Convulsants; Disease Models, Animal; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Huntington Disease; Hyperkinesis; Male; Motor Activity; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley | 2005 |
Effects of prenatal paraquat and mancozeb exposure on amino acid synaptic transmission in developing mouse cerebellar cortex.
Topics: Animals; Aspartic Acid; Cerebellar Cortex; Disease Models, Animal; Down-Regulation; Female; Fungicides, Industrial; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Herbicides; Hyperkinesis; Maneb; Mice; Motor Activity; Neural Inhibition; Paraquat; Pregnancy; Prenatal Exposure Delayed Effects; Synaptic Transmission; Zineb | 2005 |
Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris water maze reveals differences between Long-Evans and Wistar rats.
Topics: Animals; Avoidance Learning; Brain; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Hyperkinesis; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Orientation; Rats; Rats, Long-Evans; Rats, Wistar; Receptors, Glutamate; Space Perception; Species Specificity; Synaptic Transmission | 2006 |
Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission.
Topics: Actins; Analysis of Variance; Animals; Apomorphine; Cocaine; Dextroamphetamine; Dopamine; Dopamine Agents; Excitatory Amino Acid Transporter 3; Exploratory Behavior; Fibroblast Growth Factor 2; Frontal Lobe; Glutamic Acid; Hyperkinesis; Mice; Mice, Knockout; Motor Activity; Neostriatum; Nerve Fibers; Neural Pathways; Presynaptic Terminals; RNA, Messenger; Synaptic Transmission; Vesicular Glutamate Transport Protein 1 | 2007 |
MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes.
Topics: Animals; Aspartic Acid; Astrocytes; Body Water; Brain; Choline; Creatine; Diffusion; Disease Models, Animal; Disease Progression; Gliosis; Glucose; Glutamic Acid; Hyperkinesis; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Microglia; Prion Diseases | 2007 |
EphB1 null mice exhibit neuronal loss in substantia nigra pars reticulata and spontaneous locomotor hyperactivity.
Topics: Animals; Basal Ganglia Diseases; beta-Galactosidase; Biomarkers; Cell Death; Cell Differentiation; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Genes, Reporter; Glutamic Acid; Hyperkinesis; Mice; Mice, Knockout; Models, Neurological; Nerve Degeneration; Nervous System Malformations; Neural Pathways; Presynaptic Terminals; Receptor, EphB1; Substantia Nigra; Tyrosine 3-Monooxygenase | 2007 |
Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors.
Topics: Acclimatization; Animals; Corpus Striatum; Crosses, Genetic; Disease Models, Animal; Dopamine; Female; Glutamic Acid; Hyperkinesis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Receptors, AMPA; Schizophrenia; Social Behavior | 2008 |
Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Amygdala; Anesthetics, Local; Animals; Dopamine; Dopamine Agonists; Glutamic Acid; Hyperkinesis; Lidocaine; Locomotion; Male; Neural Pathways; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission | 2008 |
Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission.
Topics: Acetylcholine; Animals; Arginine Vasopressin; Brain; Calcium; Coloboma; Corticotropin-Releasing Hormone; Dopamine; Glutamic Acid; Hyperkinesis; In Vitro Techniques; Mice; Mice, Mutant Strains; Neurotransmitter Agents; Potassium Chloride; Serotonin; Synaptosomes; Tissue Distribution | 1997 |
The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
Topics: Amphetamine; Animals; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluorobenzenes; Glutamic Acid; Haloperidol; Hyperkinesis; Male; Mice; Mice, Inbred Strains; Motor Activity; N-Methylaspartate; Piperazines; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists | 1999 |
Augmented motor activity and reduced striatal preprodynorphin mRNA induction in response to acute amphetamine administration in metabotropic glutamate receptor 1 knockout mice.
Topics: Amphetamine; Animals; Caudate Nucleus; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Dynorphins; Gene Expression; Glutamic Acid; Hyperkinesis; Male; Mice; Mice, Knockout; Neural Inhibition; Nucleus Accumbens; Protein Precursors; Putamen; Receptors, Metabotropic Glutamate; RNA, Messenger; Substance P | 2001 |
Regional alterations of brain biogenic amines and GABA/glutamate levels in rats following chronic lead exposure during neonatal development.
Topics: Animals; Biogenic Amines; Body Weight; Brain; Dopamine; Dose-Response Relationship, Drug; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Hyperkinesis; Lead; Lead Poisoning; Male; Norepinephrine; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains | 1990 |